Using Genetic Risk Scores for Rheumatoid Arthritis–Associated Interstitial Lung Disease Risk Stratification

This publication has 24 references indexed in Scilit:

• Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis
  Arthritis Care & Research, 2026
• Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis–Associated Interstitial Lung Disease Subtypes
  Arthritis Care & Research, 2024
• 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
  Arthritis & Rheumatology, 2024
• Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis
  Rheumatology International, 2023
• A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease
  Arthritis & Rheumatology, 2022
• Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis
  Reumatología Clínica (English Edition), 2021
• Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing
  Mayo Clinic Proceedings, 2018
• Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis
  Clinical Rheumatology, 2015
• The Promise and Challenges of Next-Generation Genome Sequencing for Clinical Care
  JAMA Internal Medicine, 2014
• Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study
  Arthritis & Rheumatism, 2010